P-cadherin in adhesion and invasion: Opposite roles in colon and bladder carcinoma

International Journal of Cancer

Volumn 128, Issue 5, 2011, Pages 1031-1044

  Van Marck, Veerle ^a,b   Stove, Christophe ^c   Jacobs, Koen ^a   Van Den Eynden, Gert ^b   Bracke, Marc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

adhesion; bladder cancer; colorectal cancer; invasion; P cadherin

Indexed keywords

P CADHERIN; UVOMORULIN;

ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CARCINOMA CELL; CELL ADHESION; CELL AGGREGATION; CELL INVASION; CELL MOTILITY; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL;

BASE SEQUENCE; BLOTTING, WESTERN; CADHERINS; CELL ADHESION; COLONIC NEOPLASMS; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; URINARY BLADDER NEOPLASMS;

EID: 78650742441     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25427     Document Type: Article

References (47)

1. Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M, Abe O,. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 1989; 49: 2128-33.
2. Stemmler MP,. Cadherins in development and cancer. Mol Biosyst 2008; 4: 835-50.
3. Van Aken EH, De WO, Van HL, Bruyneel E, De Laey JJ, Mareel MM,. Invasion of retinal pigment epithelial cells: N-cadherin, hepatocyte growth factor, and focal adhesion kinase. Invest Ophthalmol Vis Sci 2003; 44: 463-72.
4. van Roy F, Berx G,. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008; 65: 3756-88.
5. Tinkle CL, Lechler T, Pasolli HA, Fuchs E,. Conditional targeting of E-cadherin in skin: insights into hyperproliferative and degenerative responses. Proc Natl Acad Sci U S A 2004; 101: 552-7.
6. Lo Muzio L, Pannone G, Mignogna MD, Staibano S, Mariggio MA, Rubini C, Procaccini M, Dolci M, Bufo P, De Rosa G, Piattelli A,. P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas. Histol Histopathol 2004; 19: 1089-99.
7. Sanders DS, Bruton R, Darnton SJ, Casson AG, Hanson I, Williams HK, Jankowski J,. Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma. Int J Cancer 1998; 79: 573-9.
8. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA,. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 2005; 11: 8606-14.
9. Gamallo C, Moreno-Bueno G, Sarrio D, Calero F, Hardisson D, Palacios J,. The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma. Mod Pathol 2001; 14: 650-4.
10. Stefansson IM, Salvesen HB, Akslen LA,. Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancer. J Clin Oncol 2004; 22: 1242-52.
11. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA,. A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 2007; 13: 7003-11.
12. Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, Johnson DS, Trivett MK, Etemadmoghadam D, Locandro B, Traficante N, Fereday S, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 2008; 14: 5198-208.
13. Imai K, Hirata S, Irie A, Senju S, Ikuta Y, Yokomine K, Harao M, Inoue M, Tsunoda T, Nakatsuru S, Nakagawa H, Nakamura Y, et al. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers. Clin Cancer Res 2008; 14: 6487-95.
14. Paredes J, Stove C, Stove V, Milanezi F, Van Marck V, Derycke L, Mareel M, Bracke M, Schmitt F,. P-cadherin is up-regulated by the antiestrogen ICI 182,780 and promotes invasion of human breast cancer cells. Cancer Res 2004; 64: 8309-17.
15. Taniuchi K, Nakagawa H, Hosokawa M, Nakamura T, Eguchi H, Ohigashi H, Ishikawa O, Katagiri T, Nakamura Y,. Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases. Cancer Res 2005; 65: 3092-9.
16. Jankowski JA, Bedford FK, Boulton RA, Cruickshank N, Hall C, Elder J, Allan R, Forbes A, Kim YS, Wright NA, Sanders DS,. Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis. Lab Invest 1998; 78: 1155-67.
17. Hardy RG, Tselepis C, Hoyland J, Wallis Y, Pretlow TP, Talbot I, Sanders DS, Matthews G, Morton D, Jankowski JA,. Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon. Gut 2002; 50: 513-9.
18. Milicic A, Harrison LA, Goodlad RA, Hardy RG, Nicholson AM, Presz M, Sieber O, Santander S, Pringle JH, Mandir N, East P, Obszynska J, et al. Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo. Cancer Res 2008; 68: 7760-8.
19. Shimoyama Y, Hirohashi S,. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res 1991; 51: 2185-92.
20. Yasui W, Sano T, Nishimura K, Kitadai Y, Ji ZQ, Yokozaki H, Ito H, Tahara E,. Expression of P-cadherin in gastric carcinomas and its reduction in tumor progression. Int J Cancer 1993; 54: 49-52. (Pubitemid 23136998)
21. Rieger-Christ KM, Cain JW, Braasch JW, Dugan JM, Silverman ML, Bouyounes B, Libertino JA, Summerhayes IC,. Expression of classic cadherins type I in urothelial neoplastic progression. Hum Pathol 2001; 32: 18-23.
22. Mandeville JA, Silva NB, Vanni AJ, Smith GL, Rieger-Christ KM, Zeheb R, Loda M, Libertino JA, Summerhayes IC,. P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells. BJU Int 2008; 102: 1707-14.
23. Bryan RT, Atherfold PA, Yeo Y, Jones LJ, Harrison RF, Wallace DM, Jankowski JA,. Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies. J Pathol 2008; 215: 184-94.
24. Mialhe A, Levacher G, Champelovier P, Martel V, Serres M, Knudsen K, Seigneurin D,. Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines. J Urol 2000; 164: 826-35.
25. Wiznerowicz M, Trono D,. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J Virol 2003; 77: 8957-61.
26. Stove V, Van de Walle I, Naessens E, Coene E, Stove C, Plum J, Verhasselt B,. Human immunodeficiency virus Nef induces rapid internalization of the T-cell coreceptor CD8alphabeta. J Virol 2005; 79: 11422-33.
27. Attia MA, Weiss DW,. Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus. Cancer Res 1966; 26: 1787-800.
28. Boterberg T, Bracke ME, Bruyneel EA, Mareel MM,. Cell aggregation assays. In:, Brooks S, Schumacher U,. Methods in molecular medicine, Vol. 58: Metastasis research protocols. Analysis of cell behavior in vitro and in vivo, vol. 2. Totowa: Humana Press, Inc., 2001. 33-45.
29. Bracke ME, Boterberg T, Mareel MM,. Chick heart invasion assay. In:, Brooks S, Schumacher U,. Methods in molecular medicine, vol. 58: metastasis research protocols. analysis of cell behavior in vitro and in vivo, vol. 2. Totowa: Humana Press, Inc., 2001. 91-102.
30. Stove C, Stove V, Derycke L, Van Marck V, Mareel M, Bracke M,. The heregulin/human epidermal growth factor receptor as a new growth factor system in melanoma with multiple ways of deregulation. J Invest Dermatol 2003; 121: 802-12.
31. Hamilton SR, Vogelstein B, Kudo S, Riboli E, Nakamura S, Hainaut P, Rubio CA, Sobin LH, Fogt F, Winawer SJ, Goldgar DE, Jass JR,. Carcinoma of the colon and rectum. In:, Hamilton SR, Aaltonen LA,. Pathology & genetics. Tumours of digestive system. Lyon: IARC Press, 2000. 103-19.
32. Dorudi S, Sheffield JP, Poulsom R, Northover JM, Hart IR,. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 1993; 142: 981-6.
33. Masters JR, Hepburn PJ, Walker L, Highman WJ, Trejdosiewicz LK, Povey S, Parkar M, Hill BT, Riddle PR, Franks LM,. Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res 1986; 46: 3630-6.
34. Savas B, Ensari A, Percinel S, Kuzu I, Kuzu MA, Bektas M, Cetinkaya H, Kursun N,. The significance of beta-catenin, E-cadherin, and P-cadherin expressions in neoplastic progression of colorectal mucosa: an immunohistochemical study. Acta Gastroenterol Belg 2007; 70: 339-44.
35. Bondi J, Bukholm G, Nesland JM, Bakka A, Bukholm IR,. An increase in the number of adhesion proteins with altered expression is associated with an increased risk of cancer death for colon carcinoma patients. Int J Colorectal Dis 2006; 21: 231-7.
36. Ghadimi BM, Behrens J, Hoffmann I, Haensch W, Birchmeier W, Schlag PM,. Immunohistological analysis of E-cadherin, alpha-, beta- and gamma-catenin expression in colorectal cancer: implications for cell adhesion and signaling. Eur J Cancer 1999; 35: 60-5.
37. Ngan CY, Yamamoto H, Seshimo I, Ezumi K, Terayama M, Hemmi H, Takemasa I, Ikeda M, Sekimoto M, Monden M,. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer. J Surg Oncol 2007; 95: 652-62.
38. Tsanou E, Peschos D, Batistatou A, Charalabopoulos A, Charalabopoulos K,. The E-cadherin adhesion molecule and colorectal cancer. A global literature approach. Anticancer Res 2008: 3815-26.
39. Rosivatz E, Becker I, Bamba M, Schott C, Diebold J, Mayr D, Hofler H, Becker KF,. Neoexpression of N-cadherin in E-cadherin positive colon cancers. Int J Cancer 2004; 111: 711-9.
40. Hugh TJ, Dillon SA, Taylor BA, Pignatelli M, Poston GJ, Kinsella AR,. Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br J Cancer 1999; 80: 1046-51.
41. Chantret I, Barbat A, Dussaulx E, Brattain MG, Zweibaum A,. Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines. Cancer Res 1988; 48: 1936-42.
42. Debruyne P, Vermeulen S, Mareel M,. The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta Gastroenterol Belg 1999; 62: 393-402.
43. Van Marck V, Stove C, Van Den Bossche K, Stove V, Paredes J, Vander Haeghen Y, Bracke M,. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer Res 2005; 65: 8774-83.
44. Rieger-Christ KM, Lee P, Zagha R, Kosakowski M, Moinzadeh A, Stoffel J, Ben-Ze'ev A, Libertino JA, Summerhayes IC,. Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway. Oncogene 2004; 23: 4745-53.
45. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA,. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 2000; 148: 779-90.
46. Baumgart E, Cohen MS, Silva NB, Jacobs MA, Wotkowicz C, Rieger-Christ KM, Biolo A, Zeheb R, Loda M, Libertino JA, Summerhayes IC,. Identification and prognostic significance of an epithelial-mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 2007; 13: 1685-94.
47. Lascombe I, Clairotte A, Fauconnet S, Bernardini S, Wallerand H, Kantelip B, Bittard H,. N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. Clin Cancer Res 2006; 12: 2780-7.